Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Thomas Filleron"'
Autor:
Celine Lefebvre, Thomas Bachelot, Thomas Filleron, Marion Pedrero, Mario Campone, Jean-Charles Soria, Christophe Massard, Christelle Lévy, Monica Arnedos, Magali Lacroix-Triki, Julie Garrabey, Yannick Boursin, Marc Deloger, Yu Fu, Frédéric Commo, Véronique Scott, Ludovic Lacroix, Maria Vittoria Dieci, Maud Kamal, Véronique Diéras, Anthony Gonçalves, Jean-Marc Ferrerro, Gilles Romieu, Laurence Vanlemmens, Marie-Ange Mouret Reynier, Jean-Christophe Théry, Fanny Le Du, Séverine Guiu, Florence Dalenc, Gilles Clapisson, Hervé Bonnefoi, Marta Jimenez, Christophe Le Tourneau, Fabrice André
Publikováno v:
PLoS Medicine, Vol 13, Iss 12, p e1002201 (2016)
BackgroundMajor advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limited information is available on the genomic profile of this di
Externí odkaz:
https://doaj.org/article/4906ba3a0f8142e6be54f521f2af267f
Autor:
Véronique Scott, Thomas Bachelot, Celine Lefebvre, Séverine Guiu, Jean-Marc Ferrerro, Yannick Boursin, Jean-Charles Soria, Ludovic Lacroix, Marc Deloger, Anthony Gonçalves, Maud Kamal, Fabrice Andre, Fanny Le Du, Florence Dalenc, Christophe Massard, Gilles Romieu, Yu Fu, Christophe Le Tourneau, Thomas Filleron, Marta Jimenez, Hervé Bonnefoi, Magali Lacroix-Triki, Maria Vittoria Dieci, Marion Pedrero, Julie Garrabey, J C Théry, Laurence Vanlemmens, Marie-Ange Mouret Reynier, Christelle Levy, Véronique Diéras, Monica Arnedos, Mario Campone, Gilles Clapisson, Frédéric Commo
Publikováno v:
PLoS Medicine
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Public Library of Science, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Vol 13, Iss 12, p e1002201 (2016)
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Public Library of Science, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Vol 13, Iss 12, p e1002201 (2016)
Background Major advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limited information is available on the genomic profile of this d